PE Deals

Arsenal’s deal for Hopebridge valued at ~$255 mln

-
healthcare, autism, private equity, M&A, behavioral health, ABA
KatarzynaBialasiewicz/iStock/Getty Images
  • Baird Capital investment dates to November ’17
  • Indianapolis company operates 38 autism-therapy centers
  • Gryphon entered autism-treatment space in March via LEARN

Arsenal Capital Partners’ all-cash purchase of a majority stake in Hopebridge assigns the Indianapolis autism treatment-services company an enterprise value of some $255 million, Buyouts has learned.

Share this